Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1266821.RA6haDS2OsQnhgkBB6TE8NuzzNw3xtUzDI6VdX2lRjo_E130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1266821.RA6haDS2OsQnhgkBB6TE8NuzzNw3xtUzDI6VdX2lRjo_E130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1266821.RA6haDS2OsQnhgkBB6TE8NuzzNw3xtUzDI6VdX2lRjo_E130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1266821.RA6haDS2OsQnhgkBB6TE8NuzzNw3xtUzDI6VdX2lRjo_E130_provenance.
- NP1266821.RA6haDS2OsQnhgkBB6TE8NuzzNw3xtUzDI6VdX2lRjo_E130_assertion description "[This research highlights new bioactivities for gracilins, such as BACE1 and ERK inhibition, and provides more evidence for their potential therapeutic application in neurodegenerative diseases due to their multi-target activities, especially in AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1266821.RA6haDS2OsQnhgkBB6TE8NuzzNw3xtUzDI6VdX2lRjo_E130_provenance.
- NP1266821.RA6haDS2OsQnhgkBB6TE8NuzzNw3xtUzDI6VdX2lRjo_E130_assertion evidence source_evidence_literature NP1266821.RA6haDS2OsQnhgkBB6TE8NuzzNw3xtUzDI6VdX2lRjo_E130_provenance.
- NP1266821.RA6haDS2OsQnhgkBB6TE8NuzzNw3xtUzDI6VdX2lRjo_E130_assertion SIO_000772 25724081 NP1266821.RA6haDS2OsQnhgkBB6TE8NuzzNw3xtUzDI6VdX2lRjo_E130_provenance.
- NP1266821.RA6haDS2OsQnhgkBB6TE8NuzzNw3xtUzDI6VdX2lRjo_E130_assertion wasDerivedFrom befree-2016 NP1266821.RA6haDS2OsQnhgkBB6TE8NuzzNw3xtUzDI6VdX2lRjo_E130_provenance.
- NP1266821.RA6haDS2OsQnhgkBB6TE8NuzzNw3xtUzDI6VdX2lRjo_E130_assertion wasGeneratedBy ECO_0000203 NP1266821.RA6haDS2OsQnhgkBB6TE8NuzzNw3xtUzDI6VdX2lRjo_E130_provenance.
- befree-2016 importedOn "2016-02-19" NP1266821.RA6haDS2OsQnhgkBB6TE8NuzzNw3xtUzDI6VdX2lRjo_E130_provenance.